Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol

Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol

Invasive meningococcal disease causes significant morbidity and mortality worldwide, with serogroup B being one of the predominant serogroups in Australia for many years. The South Australian (SA) State Government recently funded the introduction of a 4CMenB vaccination program for infants, children...

Full description

Bibliographic Details
Main Authors: Helen S. Marshall, Prabha H. Andraweera, Bing Wang, Mark McMillan, Ann P. Koehler, Noel Lally, Sara Almond, Emma Denehy, Michele A’Houre, Lynne C. Giles, Louise Flood
Format: Article
Language:English
Published: Taylor & Francis Group 2021-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
vaccine
4cmenb
meningitis
meningococcal disease
gonorrhoea
Online Access:http://dx.doi.org/10.1080/21645515.2020.1827614

Internet

http://dx.doi.org/10.1080/21645515.2020.1827614

Similar Items